Monika Edlinger

Summary

Affiliation: Innsbruck Medical University
Country: Austria

Publications

  1. doi request reprint Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease
    Monika Edlinger
    Department of Psychiatry and Psychotherapy, Biological Psychiatry Division, Medical University Innsbruck, Innsbruck, Austria
    Int Clin Psychopharmacol 28:214-6. 2013
  2. doi request reprint Attitudes of patients with schizophrenia and depression towards psychiatric research
    Monika Edlinger
    Medical University Innsbruck, Department of Psychiatry and Psychotherapy, University Clinic of Biological Psychiatry, Anichstrasse 35, A 6020 Innsbruck, Austria
    Psychiatry Res 177:172-6. 2010
  3. doi request reprint Factors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophrenia
    Monika Edlinger
    University Clinic of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University Innsbruck, Innsbruck, Austria
    Schizophr Res 113:246-51. 2009
  4. ncbi request reprint Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects
    Alex Hofer
    Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
    Eur Psychiatry 20:386-94. 2005
  5. ncbi request reprint Patient outcomes in schizophrenia II: the impact of cognition
    Alex Hofer
    Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
    Eur Psychiatry 20:395-402. 2005
  6. ncbi request reprint Early changes of plasma lipids during treatment with atypical antipsychotics
    Maria A Rettenbacher
    Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    Int Clin Psychopharmacol 21:369-72. 2006
  7. ncbi request reprint Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study
    Maria A Rettenbacher
    Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    J Psychopharmacol 21:400-4. 2007
  8. doi request reprint Facial emotion recognition and its relationship to symptomatic, subjective, and functional outcomes in outpatients with chronic schizophrenia
    Alex Hofer
    Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
    Eur Psychiatry 24:27-32. 2009
  9. ncbi request reprint Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective study
    Maria A Rettenbacher
    Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse, Innsbruck, Austria
    J Clin Psychopharmacol 26:500-3. 2006
  10. ncbi request reprint Prolactin levels and sexual adverse effects in patients with schizophrenia during antipsychotic treatment
    Maria A Rettenbacher
    Department of Psychiatry and Psychotherapy, Division of Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
    J Clin Psychopharmacol 30:711-5. 2010

Detail Information

Publications13

  1. doi request reprint Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease
    Monika Edlinger
    Department of Psychiatry and Psychotherapy, Biological Psychiatry Division, Medical University Innsbruck, Innsbruck, Austria
    Int Clin Psychopharmacol 28:214-6. 2013
    ..As chorea was not disabling in our patient, tetrabenazine has not yet been tried. Treatment was safe without any relevant side effects...
  2. doi request reprint Attitudes of patients with schizophrenia and depression towards psychiatric research
    Monika Edlinger
    Medical University Innsbruck, Department of Psychiatry and Psychotherapy, University Clinic of Biological Psychiatry, Anichstrasse 35, A 6020 Innsbruck, Austria
    Psychiatry Res 177:172-6. 2010
    ..Our findings confirm and extend those of other groups. This should encourage psychiatrists at least in academic settings where most of this research has been done to approach patients to take part in clinical research...
  3. doi request reprint Factors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophrenia
    Monika Edlinger
    University Clinic of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University Innsbruck, Innsbruck, Austria
    Schizophr Res 113:246-51. 2009
    ..This prospective, naturalistic study investigated the factors influencing physicians' choice of antipsychotic drug therapy in the treatment of patients with schizophrenia...
  4. ncbi request reprint Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects
    Alex Hofer
    Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
    Eur Psychiatry 20:386-94. 2005
    ..The present cross-sectional study examined the relationships of psychopathology, side effects, and sociodemographic factors with treatment outcomes in terms of patients' quality of life (QOL), functioning, and needs for care...
  5. ncbi request reprint Patient outcomes in schizophrenia II: the impact of cognition
    Alex Hofer
    Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria
    Eur Psychiatry 20:395-402. 2005
    ..Associations have been found between the severity of cognitive deficits and social dysfunction, impairments in independent living, occupational limitations, and disturbances in quality of life (QOL)...
  6. ncbi request reprint Early changes of plasma lipids during treatment with atypical antipsychotics
    Maria A Rettenbacher
    Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    Int Clin Psychopharmacol 21:369-72. 2006
    ..These results are important with regard to the increased risk for cardiovascular complications in patients with schizophrenia...
  7. ncbi request reprint Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study
    Maria A Rettenbacher
    Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    J Psychopharmacol 21:400-4. 2007
    ..None of these parameters increased significantly in patients treated with amisulpride. This study indicates that treatment with clozapine appears to have a higher risk to lead to metabolic disturbances than amisupride...
  8. doi request reprint Facial emotion recognition and its relationship to symptomatic, subjective, and functional outcomes in outpatients with chronic schizophrenia
    Alex Hofer
    Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
    Eur Psychiatry 24:27-32. 2009
    ..These findings suggest that affect recognition is an important aspect of psychosocial functioning in stable outpatients with schizophrenia...
  9. ncbi request reprint Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective study
    Maria A Rettenbacher
    Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse, Innsbruck, Austria
    J Clin Psychopharmacol 26:500-3. 2006
    ..We conclude that antipsychotic-induced elevation of liver enzymes is mostly transient and could be associated with weight gain...
  10. ncbi request reprint Prolactin levels and sexual adverse effects in patients with schizophrenia during antipsychotic treatment
    Maria A Rettenbacher
    Department of Psychiatry and Psychotherapy, Division of Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
    J Clin Psychopharmacol 30:711-5. 2010
    ..Thus, we investigated the correlation of SD and serum prolactin level in patients with schizophrenia during antipsychotic treatment...
  11. ncbi request reprint QTc variability in schizophrenia patients treated with antipsychotics and healthy controls
    Maria A Rettenbacher
    Department of Biological Psychiatry, Innsbruck University Hospital, A 6020 Innsbruck, Austria
    J Clin Psychopharmacol 25:206-10. 2005
    ....
  12. ncbi request reprint Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects
    Alex Hofer
    Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria
    J Clin Psychiatry 65:932-9. 2004
    ..Factors deemed relevant in this context include severity of symptoms, antipsychotic-induced side effects, sociodemographic variables, and patients' subjective response to medication...
  13. ncbi request reprint Switching between second-generation antipsychotics: why and how?
    Monika Edlinger
    Department of Biological Psychiatry, Innsbruck Medical University, Innsbruck, A 6020, Austria
    CNS Drugs 19:27-42. 2005
    ..We review the available evidence concerning techniques, problems and consequences when switching from one second-generation antipsychotic agent to another and discuss potential difficulties...